Harry Seifert

5PUBLICATIONS
31CO-AUTHORS
Occupational epidemiologyPreventative health careInnate immunityPacific Peoples epidemiologyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2025
Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years.

Emily Rayens, Lina S Sy, Lei Qian

|Jun 28, 2025
Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States.

Hung-Fu Tseng, Lina S Sy, Bradley K Ackerson

|Mar 21, 2024
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial.

Abdi Naficy, Adrienne Kuxhausen, Harry Seifert

|Mar 15, 2024
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States.

Ana Florea, Lina Sy, Lei Qian

|Aug 31, 2020
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.

Fernanda Tavares-Da-Silva, Olivia Mahaux, Lionel Van Holle

Pageof 1

Frequent Collaborators

3 joint publications

Leticia Vega Daily

3 joint publications

Harpreet Takhar

3 joint publications

Jennifer Ku

3 joint publications

Jeannie Song